Aldeyra's FDA Resubmission And AbbVie Option Revitalize Reproxalap's Prospects
Aldeyra received an FDA CRL for reproxalap, necessitating an additional study for DED approval. Read why I continue to rate ...
Business Insider2d
Barclays Sticks to Their Buy Rating for Replimune Group (REPL)
By upgrading to TipRanks Premium, you will gain access to this exclusive data ... patient-specific, anti-tumor immune response. The company was founded by Philip Astley-Sparke, Colin Love and Robert ...